New pill CT-996 tested for obesity and diabetes – early results promising?
Disease control
Completed
This early-stage trial tested a new drug called CT-996 in 94 overweight or obese adults, including some with type 2 diabetes. The main goal was to check safety and how the body processes the drug. Researchers gave single or multiple doses and monitored side effects. This is a fir…
Phase: PHASE1 • Sponsor: Carmot Australia First Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC